Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin
Laura M Willemsen1, Eline A Vlot2, Paul W A Janssen1
1Department of Cardiology St Antonius Hospital Nieuwegein The Netherlands.
Insights
Aspirin sensitivity in patients undergoing coronary artery bypass grafting (CABG) is linked to increased blood loss. Preoperative testing can identify those at higher risk for bleeding complications after CABG surgery.
Area of Science:
- Cardiology
- Hematology
- Surgical Research
Background:
- Aspirin is crucial for preventing thrombotic events but elevates bleeding risks.
- Managing bleeding while ensuring thrombotic event prevention is challenging in coronary artery bypass grafting (CABG) patients.
- Preoperative assessment of aspirin response may identify patients susceptible to perioperative blood loss.
Purpose of the Study:
- To compare 12-hour blood loss following CABG between aspirin-sensitive and aspirin-resistant patient groups.
- To evaluate the utility of preoperative aspirin response testing in predicting bleeding risk in CABG patients.
Main Methods:
- A substudy of the POPular CABG trial included patients on preoperative aspirin monotherapy.
- A preoperative VerifyNow aspirin assay determined aspirin sensitivity/resistance based on a cutoff of 550 aspirin reaction units.
- Primary endpoint was 12-hour postoperative blood loss; secondary endpoint included clinical bleeding events.
Main Results:
- 128 patients were analyzed: 116 aspirin-sensitive and 12 aspirin-resistant.
- Mean 12-hour blood loss was significantly higher in aspirin-sensitive patients (555 ± 278 mL) compared to aspirin-resistant patients (406 ± 110 mL) (P = .04).
- All 15 clinical bleeding events (11.7%) occurred in the aspirin-sensitive group.
Conclusions:
- Preoperative aspirin sensitivity is associated with increased 12-hour blood loss after CABG.
- VerifyNow aspirin testing can potentially identify CABG patients at high risk for perioperative bleeding.
- This testing may aid in personalized risk assessment and management strategies for CABG patients on aspirin.
Background:
Aspirin is important for preventing thrombotic events but also increases bleeding complications. Minimizing bleeding while preventing thrombotic events remains challenging in patients undergoing coronary artery bypass grafting (CABG). Establishing the patient's preoperative aspirin response could distinguish patients at risk for perioperative blood loss.
Objective:
Aim was to compare 12-h blood loss after CABG between aspirin-sensitive and aspirin-resistant patients.
Patients/Methods:
The primary analysis of this substudy of the POPular CABG trial (NCT02352402) included patients that used aspirin monotherapy preoperatively. A preoperative platelet function test by the VerifyNow aspirin assay was performed before CABG and patients were classified as aspirin-sensitive or aspirin-resistant based on an aspirin reaction units cutoff value of 550. The primary end point was 12-hour blood loss after CABG. The secondary end point was, among others, clinical bleeding events after CABG.
Results:
A total of 128 patients were included in the primary analysis. Of these, 116 patients were aspirin sensitive and 12 were aspirin resistant. Mean blood loss 12 hours after CABG was 555 ± 278 mL in aspirin-sensitive patients and 406±110 mL in aspirin-resistant patients (P = .04). All bleeding events (n = 15; 11.7%) occurred in aspirin-sensitive patients.
Conclusions:
In patients who are on aspirin preoperatively, aspirin sensitivity was associated with 12-hour blood loss after CABG, suggesting that preoperative VerifyNow aspirin testing could identify patients undergoing CABG at high risk for perioperative bleeding.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm IV: Nursing Management
Pre-Procedural Guidelines for Assessing Blood Pressure
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management

